» Articles » PMID: 36214931

Expectations for Artificial Intelligence (AI) in Psychiatry

Overview
Publisher Current Science
Specialty Psychiatry
Date 2022 Oct 10
PMID 36214931
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Artificial intelligence (AI) is often presented as a transformative technology for clinical medicine even though the current technology maturity of AI is low. The purpose of this narrative review is to describe the complex reasons for the low technology maturity and set realistic expectations for the safe, routine use of AI in clinical medicine.

Recent Findings: For AI to be productive in clinical medicine, many diverse factors that contribute to the low maturity level need to be addressed. These include technical problems such as data quality, dataset shift, black-box opacity, validation and regulatory challenges, and human factors such as a lack of education in AI, workflow changes, automation bias, and deskilling. There will also be new and unanticipated safety risks with the introduction of AI. The solutions to these issues are complex and will take time to discover, develop, validate, and implement. However, addressing the many problems in a methodical manner will expedite the safe and beneficial use of AI to augment medical decision making in psychiatry.

Citing Articles

Artificial Intelligence in Psychiatry: A Review of Biological and Behavioral Data Analyses.

Baydili I, Tasci B, Tasci G Diagnostics (Basel). 2025; 15(4).

PMID: 40002587 PMC: 11854694. DOI: 10.3390/diagnostics15040434.


Physician Perspectives on the Potential Benefits and Risks of Applying Artificial Intelligence in Psychiatric Medicine: Qualitative Study.

Stroud A, Curtis S, Weir I, Stout J, Barry B, Bobo W JMIR Ment Health. 2025; 12:e64414.

PMID: 39928397 PMC: 11851033. DOI: 10.2196/64414.


Evaluating the Clinical Validity and Reliability of Artificial Intelligence-Enabled Diagnostic Tools in Neuropsychiatric Disorders.

Singh S, Gambill J, Attalla M, Fatima R, Gill A, Siddiqui H Cureus. 2024; 16(10):e71651.

PMID: 39553014 PMC: 11567685. DOI: 10.7759/cureus.71651.


A review on the efficacy of artificial intelligence for managing anxiety disorders.

Das K, Gavade P Front Artif Intell. 2024; 7:1435895.

PMID: 39479229 PMC: 11523650. DOI: 10.3389/frai.2024.1435895.


The Role of Artificial Intelligence in Identifying Depression and Anxiety: A Comprehensive Literature Review.

Zafar F, Fakhare Alam L, Vivas R, Wang J, Whei S, Mehmood S Cureus. 2024; 16(3):e56472.

PMID: 38638735 PMC: 11025697. DOI: 10.7759/cureus.56472.


References
1.
Kirtley O, van Mens K, Hoogendoorn M, Kapur N, de Beurs D . Translating promise into practice: a review of machine learning in suicide research and prevention. Lancet Psychiatry. 2022; 9(3):243-252. DOI: 10.1016/S2215-0366(21)00254-6. View

2.
Stetson P, Cantor M, Gonen M . When Predictive Models Collide. JCO Clin Cancer Inform. 2020; 4:547-550. PMC: 8462634. DOI: 10.1200/CCI.20.00024. View

3.
Fleuren L, Thoral P, Shillan D, Ercole A, Elbers P . Machine learning in intensive care medicine: ready for take-off?. Intensive Care Med. 2020; 46(7):1486-1488. DOI: 10.1007/s00134-020-06045-y. View

4.
Finlayson S, Bowers J, Ito J, Zittrain J, Beam A, Kohane I . Adversarial attacks on medical machine learning. Science. 2019; 363(6433):1287-1289. PMC: 7657648. DOI: 10.1126/science.aaw4399. View

5.
Scott I, Carter S, Coiera E . Exploring stakeholder attitudes towards AI in clinical practice. BMJ Health Care Inform. 2021; 28(1). PMC: 8663096. DOI: 10.1136/bmjhci-2021-100450. View